SNC
IDXX icon

Stifel Nicolaus & Co’s Idexx Laboratories IDXX Stock Holding History

Stifel Nicolaus & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$243K Buy
4,874
+274
+6% +$13.2K ﹤0.01% 1257
2013
Q2 		$206K Buy
+4,600
New +$201K ﹤0.01% 1262

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Nicolaus & Co's IDXX Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Idexx Laboratories (IDXX) stake by 6% in Q3 2013, buying an estimated $13.2K and bringing the position to 4,874 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Stifel Nicolaus & Co first reported a position in IDXX in Q2 2013 and has held it in 2 quarters since. 274 funds tracked by Wall St. Rank hold IDXX as of Q3 2013.

  • Stifel Nicolaus & Co held 4,874 shares of Idexx Laboratories worth $243K as of Q3 2013.
  • Stifel Nicolaus & Co bought 274 Idexx Laboratories shares in Q3 2013, an estimated $13.2K.
  • Idexx Laboratories made up ﹤0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1257 holding.
  • Stifel Nicolaus & Co first reported a position in Idexx Laboratories in Q2 2013 and has held it in 2 quarters since.
  • 274 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.